SYNTAX score. Number & location of lesions. Dominance. Left Main. Calcification. 3 Vessel. Thrombus. Total Occlusion. Bifurcation.
|
|
- Howard Rich
- 6 years ago
- Views:
Transcription
1 PCI vs CABG for Multivessel Disease: Calculatio of Risk ad Log Term Outcome Pawel Buszma, MD, PhD, FESC, FACC Professor of Medicie, Medical Uiversity of Silesia, Katowice, Polad TCT AP 2010
2 Strategy qlocal Heart team (surgeo & itervetioal cardiologist) assessed each patiet i regards to: qpatiet s operative risk (EuroSCORE & Parsoet score, Clevelad score) qoperative risk scores predict perioperative ad i-hospital surgical risk of death or sever complicatios qcoroary lesio complexity (SYNTAX score) qsyntax score provides guidace o optimal revascularizatio strategies for patiets with high-risk lesios based o results of SYNTAX Study qpci risk score: risk of techical failure ad hemodyamic collapse qpredictio of log term outcome ( years) after PCI ad CABG
3 Assessemet of extet of coroary artery disease SYNTAX Score: Calcificatio Domiace Number & locatio of lesios Left Mai Thrombus SYNTAX score 3 Vessel Bifurcatio Total Occlusio Tortuosity EuroIterv 2005;1:
4 Sytax score vs 12/12 outcome
5 Logistic EuroScore Age Sex (per 5 years or part thereof over 60 years) 1 female Chroic pulmoary disease Extracardiac arteriopathy logterm use of brochodilators or steroids for lug disease 1 ay oe or more of the followig: claudicatio, carotid occlusio or >50% Extracardiac arteriopathy ay oe or more of the followig: claudicatio, carotid occlusio or >50% steosis, previous or plaed itervetio o the abdomial aorta,limb arteries or carotids 2 Neurological dysfuctio disease severely affectig ambulatio or day-to-day fuctioig 2 Previous cardiac surgery Serum creatiie Active edocarditis requirig opeig of the pericardium 3 >200m micromol/l preoperatively 2 patiet still uder atibiotic treatmet for edocarditis at the time of surgery 3 ay oe or more of the followig: vetricular tachycardia or fibrillatio or Critical preoperative state aborted sudde death, preoperative cardiac massage, preoperative vetilatio before arrival i the aaesthetic room,preoperative iotropic support, itraaortic balloo couterpulsatio or preoperative acute real failure (auria or oliguria<10 ml/hour) 3 Cardiac-related related factors Ustable agia 2 LV dysfuctio Score rest agia requirig iv itrates util arrival i the aaesthetic room moderate or LVEF30-50% 1 poor or LVEF <30 3 Recet myocardial ifarct Pulmoary hypertesio 2 Operatio-related related factors Emergecy 2 Other tha isolated CABG (<90 days) 2 Systolic PA pressure>60 mmhg Score carried out o referral before the begiig of the ext workig day major cardiac procedure other tha or i additio to CABG 2
6 EuroScore calculator: additive ad logistic
7 Euroscore - calculator
8 SYNTAX TRIAL: Predictors of CABG Variable 12 moth MACCE: Pre- procedure Odds Ratio [95% CI] P value COPD 2.45 [1.25, 4.80] Ustable Agia 1.88 [1.14, 3.09] 0.01 Moderate or Poor LVEF 1.98 [1.13, 3.47] 0.02 SYNTAX Score 0.97 [0.95, 1.00] 0.02 Race 0.33 [0.14, 0.82] 0.02 Emerget Revasc [1.08, 7.17] 0.03 Prior MI 0.57 [0.33, 0.99] Age 1.03 [1.00, 1.05] TAXUS Medically Treated Diabetes 2.07 [1.40, 3.05] <0.001 SYNTAX Score 1.02 [1.00, 1.04] 0.02 Age 1.02 [1.00, 1.04] 0.03
9 Sytax Trial Euroscore additive Sytax Score 1 year mortality 1 year MACE PCI RCT 3,8 28,4 4,3 17,8 CABG RCT 3,8 29,1 3,5 12,1 PCI Reg. 5,8 31,6 7,4 20,5 CABG Reg 3,8 35,5 2,5 8,8
10 Decisio diagram EuroScore High Risk PCI PCI??? (PCI vs Rx?) 5 Low Risk PCI PCI or CABG: LM = PCI 3vd ad DM = CABG CABG >33 Sytax Score
11 High risk populatio Acute coroary sydrome patiets LMCA disease Depressed LV fuctio Diabetes, Real Failure etc.
12 LE MANS Registry (=252)
13 LE MANS REGISTRY Results: ui ad multivariate aalysis with Odds Ratio for log term follow-up Age >60 y.o. LVEF<50% Stet diam.<3,8mm DES p=0,03 OR:2,48 (1,03-5,95 p=0,01 OR:3,25 (1,45-7,27) p=0,04 OR:2,48 (0,99-5,7) p=0,11 OR:0,53 (0,23-1,18) Euroscore>9 p=0,04 OR:2,48 (1,1-4,56) The Cox multivariate aalysis for idepedet risk factors showed that EF<50% decreased survival rate, while DES implatatio decreased ad stet diameter <3,8mm icreased the risk of MACCE.
14 ACS Registry PL-ACS ( pts i Polad) Substudy: revascularizatio for MVD i 3787 pts (Years ) 2009)
15 Results 30 day mortality p=0,1
16 PCI better tha CABG for MVCAD ad NST-ACS? 100% 98% 96% 94% 92% 90% 88% 86% 84% 82% 80% 78% 76% 74% 72% 70% Two years cumulative survival: PCI vs. CABG Time (days) CABG PCI
17 Sigle ad idepedet risk factors ifluecig log term mortality i ACS + MVCAD CABG* Male Ustable Agia NSTEMI Cardiogeic shock * Tobacco Hypertesio Dyslipidemia Diabetes Obesity Prior MI Prior CABG Prior PCI * Idepedet risk factor 0, Odds ratio
18 DES for ACS subaalysis of all comers studies AHP Registry
19 Sigle risk / beefit factors ifluecig 2 year mortality Age>65 Male Ustable agia NSTEMI STEMI Killip>1 Euroscore<7 BMI>27 Hypertesio DM Obesity Tobacco Hyperlipidemia Family History Creatiie>0,9 COPD prior MI prior PCI prior CABG 0,0316 0,3162 3, ,6228 Odds ratio
20 Sigle risk / beefit factors ifluecig 2 year mortality Sigle risk / beefit factors ifluecig two year mortality LVEF<50% MVD LM disease 2 d ge DES Cypher Biomatrix Edeavor Xiece Stet diam.<3,0 Resteotic lesio CTO predilatatio Complete revasc GPI 0,0316 0,3162 3, ,6228 Odds ratio
21 100% 100% 99% 99% 98% 98% 97% 97% 96% 96% 95% 95% 94% 94% 93% 93% 92% 92% 91% 91% 90% Cumulative survival: DES 1 st ge vs DES 2 d ge F-Cox p = 0, Time (days) DES 2d ge DES 1st ge
22 PCI scorig system to predict early ad log term outcome Cliical risk factors: SA/UA/NSTEMI/STEMI Killip class LV fuctio Biomarkers Risk of bleedig Atiplatelet pre-treatmet, bedside platelet reactivity Diabetes Mellitus, Real Failure, PAD Hyperlipidemia ad pre-treatmet with statis
23 PCI scorig system to predict early ad log term outcome Agiographic risk vessel CAD LMCA disease Sytax score! Peri- ad post PCI risk (residual risk) DES vs BMS No of stets Overlappig stets Appositio ad strut expasio, residual steosis (IVUS!) adge dissectio Prox/dist lesios, TIMI flow post PCI Complete revascularizatio Bleedig, MI
24 Algorhytm to predict outcome after PCI or CABG Based o data from the large registries ad radomized trials (PCI, CABG) a risk calculator should be desiged to predict the late outcome after PCI or CABG i a particular case!
25 Previous experiece Patiet Specific Predictios ad Comparisos for Patiets with Coroary Artery Disease. DC Naftel, EH Blackstoe, JW Kirkli Software ver.1.0, Summit Medical Systems JACC 1991;17: Circulatio 1991;83: (data icludig ca 6000 CABG ad 300 PCI pts)
26 The Cardiologist as a gatekeeper Is recascularizatio ecessary? Yes, if progostic or symptomatic idicatios Ca we perform PCI? Yes, if techically feasible at low periprocedural risk Ca we do it as good as the surgeos? Log term results? SYNTAX score, EUROSCORE, PCI/CABG calculator? Should I do it? Oly if the experiece i multivessel, complex
27 SYNTAX Score: guidig selectio of revascularizatio
28 Sytax Score Examples Left Mai Radomized Score 25 LM & 3VD Radomized Score 39 LM & 3VD Registry Score 50
29 Euroscore - calculator
30 100% Euroscore > 7 vs <7 99% 98% 97% 96% 95% F-Cox p = 0,01 94% 93% 92% 91% 90% Time (days) ES < 7 ES > 7
31 100% DM vs. o DM 99% 98% 97% F-Cox p = 0,02 96% 95% 94% 93% 92% Time (days) DM
32 MACCE at 12 Moths by SYNTAX Score Tercile All Terciles PCI Registry Cumulative Evet Rate (%) High (³33) Itermediate (23-32) 16.1% 16.1% Low (0-22) Moths Sice Allocatio 26.9% Kapla-Meier rates Per-protocol populatio
33 Overall MACCE to 12 Moths TAXUS RCT ad PCI Registry TAXUS RCT* (=903) PCI Reg (=192) Cumulative Evet Rate (%) % % Moths Sice Allocatio Evet Rate ± 1.5 SE * For descriptive purposes oly; o statistical comparisos doe Per-protocol populatio Kapla-Meier rates
MICHELANGELO: OASIS 5 Women s Substudy
MICHELANGELO: OASIS 5 Wome s Substudy Dr. Eva Swah Departmet of Cardiology, Heart Cetre, Uiversity Hospital, Liköpig Swede Disclosure Fuded by Saofi-Sythelabo, Orgao NV ad GSK Dr. Swah has o coflicts of
More informationEXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017
EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 Igor F. Palacios, MD Director of Interventional Cardiology Professor of Medicine Massachusetts
More informationCan Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!
Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,
More informationPCI vs. CABG From BARI to Syntax, Is The Game Over?
PCI vs. CABG From BARI to Syntax, Is The Game Over? Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea PCI vs CABG Multi-Vessel Disease
More informationCOMMENT DEFINIR UN PLURITRONCULAIRE. Didier Carrié CHU Toulouse Rangueil
COMMENT DEFINIR UN PLURITRONCULAIRE VISION ANGIOGRAHIQUE DU PLURITRONCULAIRE Didier Carrié CHU Toulouse Rangueil Congrès GRCI 03 Décembre 2010 Pôle Cardiovasculaire et Métabolique Avec quel œil je regarde
More informationLeft Main Intervention: Where are we in 2015?
Left Main Intervention: Where are we in 2015? David A. Cox, MD FSCAI Director, Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown, PA Fall Fellows Course Laa
More informationhigh SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin Turin / Italy
What to do with patients with high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin San Giovanni Battista Hospital Turin / Italy Who are the patients with high SYNTAX
More informationLeft Main Intervention: Will it become standard of care?
Left Main Intervention: Will it become standard of care? David Cox, MD FSCAI, FACC Director, Interventional Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown,
More informationPCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France
PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease
More informationThe SYNTAX-LE MANS Study
The SYNTAX-LE MANS Study Synergy Between PCI with TAXUS Express and Cardiac Surgery: Late (15-month) Left Main Angiographic Substudy A. Pieter Kappetein, MD, PhD Erasmus MC, Rotterdam, NL SYNTAX-LE MANS
More informationPROMUS Element Experience In AMC
Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationAbstract Aims: To evaluate the angiographic and clinical outcome of patients undergoing paclitaxel-eluting stent CLINICAL RESEARCH
CLINICAL RESEARCH DOI: 10.4244/EIJV7I6A110 Early ad log-term results of uprotected left mai coroary artery steosis with paclitaxel-elutig stets: the FRIEND (Frech multicetre registry for stetig of uprotected
More informationReconciling the Results of the Randomized Trials
Management of Stable Angina in Multivessel Disease: Reconciling the Results of the Randomized Trials Eric A. Cohen MD, FRCPC Schulich Heart Centre Sunnybrook Health Sciences Centre Toronto ON ACC Rockies
More informationIVUS vs FFR Debate: IVUS-Guided PCI
IVUS vs FFR Debate: IVUS-Guided PCI Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Disclosure Statement of Financial Interest Within the past 12 months, I have had a financial interest/arrangement
More informationINFORMATION FOR YOU AND YOUR FAMILY. Melody Transcatheter Pulmonary Valve Therapy
INFORMATION FOR YOU AND YOUR FAMILY Melody Trascatheter Pulmoary Valve Therapy This booklet is provided to help you ad your loved oes lear more about Melody Trascatheter Pulmoary Valve (TPV) Therapy. Please
More informationMise à Jour sur le traitement du Pluritronculaire Philippe Généreux, MD
Mise à Jour sur le traitement du Pluritronculaire Philippe Généreux, MD Columbia University Medical Center and The Cardiovascular Research Foundation, New York, USA Hôpital du Sacré-Coeur de Montréal,
More informationLeft Main and Bifurcation Summit I. Lessons from European LM Studies
Left Main and Bifurcation Summit I Apr 29 8.56-9.09 Lessons from European LM Studies Alaide Chieffo, MD S. Raffaele Hospital, Milan, Italy Nothing to disclose regarding this presentation Lesion Location
More informationDiabetic Patients: Current Evidence of Revascularization
Diabetic Patients: Current Evidence of Revascularization Alexandra J. Lansky, MD Yale University School of Medicine University College of London The Problem with Diabetic Patients Endothelial dysfunction
More informationUnprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
More informationPatients in whom PCI is preferred over CABG _ Aleksander Ernst Clinical Hospital Center Zagreb University of Zagreb School of Medicine Zagreb, CROATIA
3rd Dubrovnik Cardiology Highlights An ESC Update Programme in Cardiology 26.09.-29.09.2013, Hotel Excelsior, Dubrovnik, Croatia Patients in whom PCI is preferred over CABG _ Aleksander Ernst Clinical
More informationQuick Reference to Transthoracic Echo Screening
Quick Referece to Trasthoracic Echo Screeig Idicatio: The MitraClip Clip Delivery System is idicated for the percutaeous reductio of sigificat symptomatic mitral regurgitatio (MR 3+) due to primary abormality
More informationWhat is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?
What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,
More informationDiagnostic, Technical and Medical
Diagnostic, Technical and Medical Approaches to Reduce CABG Related Stroke Pieter Kappetein, Michael Mack, M.D. Dept Thoracic Surgery, Rotterdam, The Netherlands Baylor Healthcare System Dallas, TX Background
More informationRationale for Percutaneous Revascularization ESC 2011
Rationale for Percutaneous Revascularization Marie Claude Morice, Massy FR MD, FESC, FACC ESC 2011 Paris Villepinte - 27-31 August, 2011 Massy, France Potential conflicts of interest I have the following
More informationSurgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome
Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures
More informationControversies in Coronary Revascularization. Atlanta CCU April 15, 2016
Controversies in Coronary Revascularization Atlanta CCU April 15, 2016 Habib Samady MD FACC FSCAI Professor of Medicine Director, Interventional Cardiology, Emory University Director, Cardiac Catheterization
More informationMichael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX
Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX Maquet, Inc.,- unpaid consultant Cordis, Inc.,- unpaid consultant Boston Scientific, Inc.,- travel expenses paid for Syntax
More informationControversies in Cardiac Surgery
Controversies in Cardiac Surgery 3 years after SYNTAX : Percutaneous Coronary Intervention for Multivessel / Left main stem Coronary artery disease Pro ESC Congress 2010, 28 August 1 September Stockholm
More informationClinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective
Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical
More informationMichael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX
Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX Boston Scientific, Inc.- Syntax Trial Steering Committee Member- travel expenses paid by trial sponsor Maquet, Inc.- unpaid
More informationCABG vs PCI: What do the Guidelines Say?
AATS International Cardiovascular Symposium: Sao Paolo 2017 CABG vs PCI: What do the Guidelines Say? David P Taggart MD PhD FRCS FESC Professor of Cardiovascular Surgery, University of Oxford Conflicts
More informationR&M Solutions
PCI with DES versus CABG & syntax score Dr. Mohamed Sobhy, MD, FACC, FESC Professor of Cardiology, Alexandria University, Egypt Head of Cardiology Department President of Egyptian Society of Cardiology
More informationUnprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy
Unprotected Left Main Stenting: Patient Selection and Recent Experience Alaide Chieffo S. Raffaele Hospital, Milan, Italy Class IIa (Level B) AHA/ACC 2005 Guidelines Left Main CAD The use of PCI for pts
More informationSurgery Grand Rounds
Surgery Grand Rounds Coronary Artery Bypass Grafting versus Coronary Artery Stenting Charles Ted Lord, R1 Coronary Artery Disease Stenosis of epicardial vessels Metabolic & hematologic Statistics 500,000
More informationManagement of cardiovascular disease - coronary interventions -
Master Classes in Preventive Cardiology I Management of diabetes in patients with CVD European Heart House Management of cardiovascular disease - coronary interventions - Francesco Cosentino MD, PhD, FESC
More informationClinical Considerations for CTO
38 RCTs Clinical Considerations for CTO 18,000 pts Revascularization Whom to treat, Who derives benefit and What can we achieve? David E. Kandzari, MD FACC, FSCAI Director, Interventional Cardiology Research
More informationResolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program
Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Prof. Ran Kornowski, MD, FESC, FACC Director - Division of Interventional Cardiology Rabin Medical Center and Tel Aviv University,
More informationLe# Main Interven-on: When Is It Appropriate. Femi Philip, MD Assistant Professor Of Medicine UC Davis
Le# Main Interven-on: When Is It Appropriate Femi Philip, MD Assistant Professor Of Medicine UC Davis Nil Disclosures Outline What is the LMCA? Should we revascularize severe LMCA disease? What revascularizacon
More informationCoronary interventions
Controversial issues in the management of ischemic heart failure Coronary interventions Maciej Lesiak Department of Cardiology, University Hospital in Poznan none DECLARATION OF CONFLICT OF INTEREST CHF
More informationDrug Eluting Stents: Bifurcation and Left Main Approach
TCT Asia 2006 Drug Eluting Stents: Bifurcation and Left Main Approach Eberhard Grube MD FACC, FSCAI Heart Center,, Germany Stanford University, School of Medicine, CA, USA DES in High Risk Lesions TAXUS
More informationOff-Pump Coronary Artery Bypass (OPCAB) surgery is
Off-Pump Coroary Artery Bypass () Surgery Reduces Risk-Stratified Morbidity ad Mortality: A Uited Kigdom Multi-Ceter Comparative Aalysis of Early Cliical Outcome Sharif Al-Ruzzeh, FRCS; Gareth Ambler,
More informationACE-27 with Dr. Piccirillo from Washington University St. Louis. August 18, 2009
ACE-27 with Dr. Piccirillo from Washigto Uiversity St. Louis August 18, 2009 Itroductio Patiets with cacer ofte have other diseases, illesses, or coditios i additio to their idex cacer These other coditios
More informationFAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS
Coronary Physiology In The Cathlab FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS Educational Training Program ESC European Heart House april 7th 9th 2011 Nico H.J.Pijls, MD, PhD Catharina Hospital,
More informationAbstract Aims: The current study reports clinical outcomes at three year follow-up of the LEADERS clinical trial CLINICAL RESEARCH
CLINICAL RESEARCH The three year follow-up of the radomised all-comers trial of a biodegradable polymer biolimus-elutig stet versus permaet polymer sirolimus-elutig stet (LEADERS) Joaa Wykrzykowska 1,
More informationLessons learned From The National PCI Registry
Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients
More informationWhen should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER
When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER ICPS, Massy ICV-GVM La Roseraie, Aubervilliers Hôpital FOCH, Suresnes Disclosure Statement of Financial
More informationBIOFLOW-III an all comers registry with a Sirolimus Eluting Stent: Presentation of 1-Year TLF Data in patients with complex lesions
BIOFLOW-III an all comers registry with a Sirolimus Eluting Stent: Presentation of 1-Year TLF Data in patients with complex lesions Johannes Waltenberger, MD, F.E.S.C. Uniklinik Münster Münster, Germany
More informationFFR in Multivessel Disease
FFR in Multivessel Disease April, 26 2013 Coronary Physiology in the Catheterization Laboratory Location: European Heart House, Nice, France Pim A.L. Tonino, MD, PhD Hartcentrum, Eindhoven, the Netherlands
More informationFractional Flow Reserve and the Results of the FAME Study
Imaging and Physiology Summit Seoul, Korea November 21 st, 2009 Fractional Flow Reserve and the Results of the FAME Study William F. Fearon, M.D. Assistant Professor Division of Cardiovascular Medicine
More informationPTCA 1979: : I
The SYNTAX Message is Clear: CABG is Preferred in Complex MVD Angioplasty Summit TCTAP 2012 Seoul, Korea April 2012 David R. Holmes, MD Mayo Clinic Rochester, MN Presenter Disclosure Information David
More informationAsian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017
Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Trends of acute myocardial infarction in Korea from the experience of Korea Acute
More informationImportant LM bifurcation studies update
8 th European Bifurcation Club 12-13 October 2012 - Barcelona Important LM bifurcation studies update I Sheiban E-mail: isheiban@yahoo.com Unprotected LM Percutaneous Revascularization What is important
More informationAlex versus Xience Registry Preliminary report
Interventional Cardiology Network Alex versus Xience Preliminary report Mariusz Gąsior 1,2, Marek Gierlotka 1, Lech Poloński 1,2 1 3rd Department of Cardiology, Medical University of Silesia Centre tor
More informationWhat do the guidelines say?
Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European
More informationModified Early Warning Score Effect in the ICU Patient Population
Lehigh Valley Health Network LVHN Scholarly Works Patiet Care Services / Nursig Modified Early Warig Score Effect i the ICU Patiet Populatio Ae Rabert RN, DHA, CCRN, NE-BC Lehigh Valley Health Network,
More informationThe Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study Five-Year Results in the French Subset René Koning, MD On behalf of the SYNTAX investigators Three-year
More informationImplications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011
Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011 Prof. Dr. Volkmar Falk Klinik für Herz- und Gefäßchirurgie, Universitätsspital Zürich, Schweiz In 2004 headlines were
More informationLeft Main Disease: what is left to surgery? Prof. Jacques Monségu CardioVascular Institute Grenoble, France
Left Main Disease: what is left to surgery? Prof. Jacques Monségu CardioVascular Institute Grenoble, France Background on LM stenosis 5% of patients undergoing angiography Of the myocardium 80% Bifurcation
More informationPrimary: To assess the change on the subject s quality of life between diagnosis and the first 3 months of treatment.
Study No.: AVO112760 Title: A Observatioal Study To Assess The Burde Of Illess I Prostate Cacer Patiets With Low To Moderate Risk Of Progressio Ratioale: Little data are available o the burde of illess
More informationΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΣΤΟ ΔΙΑΒΗΤΙΚΟ ΑΣΘΕΝΗ
ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΣΤΟ ΔΙΑΒΗΤΙΚΟ ΑΣΘΕΝΗ Νίκος Μεζίλης MD, FESC Κλινική Άγιος Λουκάς Why diabetes is associated with restenosis endothelial dysfunction metabolic alterations accelerated platelet deposition
More informationRESTENOSIS Facing up to the problem
RESTENOSIS Facing up to the problem Petr Kala University Hospital Brno Czech Republic ESC 2011, Paris Disclosure Scientific Advisory Boards or Education presentations fee Abbott, Boston Scientific, Cordis
More informationApproach to Multi Vessel disease with STEMI
Approach to Multi Vessel disease with STEMI MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION Dr. Thomas Alexander, M.D; D.M; F.A.C.C. Senior Consultant and Interventional Cardiologist Kovai Medical Centre
More informationClinical Considerations for CTO Revascularization
Clinical Considerations for CTO Revascularization Whom to treat, Who derives benefit and What can we achieve? David E. Kandzari, MD, FACC, FSCAI Chief Medical Officer Cordis Cardiology Johnson & Johnson
More informationKomplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents
Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Prof. Dr. med. Julinda Mehilli Medizinische Klinik und Poliklinik I Klinikum der Universität München Campus Großhadern Key Factors
More informationLM stenting - Cypher
LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with
More informationFractional Flow Reserve: Review of the latest data
Fractional Flow Reserve: Review of the latest data Michalis Hamilos, MD, PhD, FESC University Hospital of Heraklion Fractional Flow Reserve (FFR) Coronary angiography does not always tell the truth Most
More informationAssessing Myocardium at Risk: Applying SYNTAX
Assessing Myocardium at Risk: Applying SYNTAX Farouc Jaffer MD PhD FSCAI FACC FAHA Associate Professor of Medicine, Harvard Medical School Director, CAD Program and Chronic Total Occlusion PCI Program
More informationManagement of High-Risk CAD : Surgeons Perspective
Management of High-Risk CAD : Surgeons Perspective Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan Conflict : Cardiac Surgeon! High Risk CABG 77 year old with prior large anterior
More informationPCI for LMCA lesions A Review of latest guidelines and relevant evidence
HCS Working Group Seminars Met Hotel, Thursday 14 th February 2013 PCI for LMCA lesions A Review of latest guidelines and relevant evidence Vassilis Spanos Interventional Cardiologist, As. Director 3 rd
More informationFFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford
4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea FFR-Guided PCI William F. Fearon, M.D. Associate Professor Division of Cardiovascular Medicine University Medical Center Disclosure Statement
More informationISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions
Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main
More informationImpact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy.
Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy. GENNARO SARDELLA, MD, FACC,FESC; MASSIMO MANCONE,
More informationEuro-Asia CTO Club Can we Implement Japanese Techniques in Europe?
Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe? T. Lefèvre,, Massy, France Background Despite continuous improvement, PTCA of chronic total occlusion remains a real technical challenge.
More informationPercutaneous Intervention of Unprotected Left Main Disease
Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected
More informationPCI Update Qesaria 2009
PCI Update Qesaria 2009 Amit Segev Interventional Cardiology Chaim Outline Primary PCI Non-ST elevation ACS Multi-vessel disease Hemodynamic assessment of borderline lesions - FFR Stable AP Non-coronary
More informationFractional Flow Reserve (FFR) Measurement System Value Dossier
PressureWire Fractioal Flow Reserve (FFR) Measuremet System Value Dossier The St. Jude Medical PressureWire Measuremet System for Fractioal Flow Reserve (FFR) Measuremet i Coroary Artery Steosis The PressureWire
More informationCOMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands
COMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands TCTAP 2010 Seoul, Korea Disclosures Research Foundation of the Cardiology Department has received unrestricted research grants from:
More informationPeriprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion
Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol
More informationAbstract Aims: Smaller studies have previously shown promising results after Tryton Side Branch Stent (Tryton CLINICAL RESEARCH
CLINICAL RESEARCH Six-moth ad oe-year cliical outcomes after placemet of a dedicated coroary bifurcatio stet: a patiet-level pooled aalysis of eight registry studies Maik J. Grudeke 1, MD; Solomo Asgedom
More informationMost Patients with Elective Left Main Disease. Farrel Hellig
Most Patients with Elective Left Main Disease Should be Treated with PCI! Farrel Hellig Sunnnghill and Sunward Park Hospitals Johannesburg South Africa Everything that can be invented has been invented
More informationPreoperative Cardiac Risk Assessment: Approach & Guidelines
Preoperative Cardiac Risk Assessment: Approach & Guidelines By, Liam Morris, MD., FACC (02/03/18) CPG : Clinical Practice Guidelines GDMT : Guidelines Directed Medical Therapy GWC : Guideline Writing Committee
More informationBeta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National
More informationInspiron Stent. Clinical Research Program. Pedro A. Lemos MD PhD. Heart Institute InCor University of Sao Paulo Medical School Sao Paulo Brazil
Stent Clinical Research Program Pedro A. Lemos MD PhD Heart Institute InCor University of Sao Paulo Medical School Sao Paulo Brazil All faculty disclosures are available on the CRF Events App and online
More informationManagement of High-Risk Coronary Artery Disease
Management of High-Risk Coronary Artery Disease Jeffrey J. Popma, MD Director, Interventional Cardiology Clinical Services Beth Israel Deaconess Medical Center Associate Professor of Medicine Harvard Medical
More informationPerspective of LM stenting with Current registry and Randomized Clinical Data
Asian Pacific TCT Perspective of LM stenting with Current registry and Randomized Clinical Data Patrick W. Serruys MD PhD Yoshinobu Onuma MD Seung-Jung Park MD, PhD 14:48-15:00, 2009 Symposium Arena, Level
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationUnprotected left main coronary stenting with a second generation drug-eluting stent. One-year clinical follow-up of the LeMaX pilot study.
Unprotected left main coronary stenting with a second generation drug-eluting stent. One-year clinical follow-up of the LeMaX pilot study. N. Boudou, N. Salvatella, N. Dumonteil, M.C. Morice, O. Darremont,
More informationEarly Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Introduction/Background. Research Team.
Research Team Early Ambulatio Reduces the Risk of Veous Thromboembolism After Total Kee Replacemet Marily Szekedi, PhD, RN Baafsheh Sadeghi, MD, PhD, School of Medicie, Uiversity of Califoria Davis Patrick
More informationCardiogenic Shock. Carlos Cafri,, MD
Cardiogenic Shock Carlos Cafri,, MD SHOCK= Inadequate Tissue Mechanisms: Perfusion Inadequate oxygen delivery Release of inflammatory mediators Further microvascular changes, compromised blood flow and
More informationCindy L. Grines MD FACC FSCAI
Cindy L. Grines MD FACC FSCAI Hofstra Northwell School of Medicine Chair, Cardiology Academic Chief of Cardiology, Northwell Health North Shore University Hospital, Manhasset NY Multivessel Disease in
More informationMedical Rx vs PCI vs CABG
Medical Rx vs PCI vs CABG S. Hinan Ahmed, MD Associate Professor: Cardiology and Cardiothoracic Surgery Program Director: Interventional Fellowship Program Assoc Editor: Cath and Cardiovasc Intervention
More informationBenefit of Performing PCI Based on FFR
Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided
More informationANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April The problem is exaggerated: Data from Real World Registries
ANGIOPLASY SUMMIT 007 TCT ASIA PACIFIC Seoul, Korea: 5-7 7 April 007 15 min Plenary Session: State-of of-the-art Lectures The problem is exaggerated: Data from Real World Registries Antonio Colombo Centro
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationDisclosures. Theodore A. Bass MD, FSCAI. The following relationships exist related to this presentation. None
SCAI Fellows Course December 10, 2013 Disclosures Theodore A. Bass MD, FSCAI The following relationships exist related to this presentation None Current Controversies on DAPT in PCI Which drug? When to
More informationMyocardial revascularisation in multivessel disease: The value of risks scores
Myocardial revascularisation in multivessel disease: The value of risks scores ESC 2012 Marie Claude Morice, Darren Mylotte, Institut cardiovasculaire Paria Sud, Massy,France Declaration of conflict of
More informationRadiation Exposure During Percutaneous Coronary Interventions and Coronary Angiograms Performed by the Radial Compared With the Femoral Route
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 5, NO. 7, 2012 2012 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jci.2012.03.020
More informationDEMAND RESULTS. TRUST ENDURANT.
DEMAND RESULTS. TRUST ENDURANT. Edurat ll AAA Stet System Edurat IIs AAA Stet System THE ENDURANT II SYSTEM FAMILY OF PRODUCTS Icludes Edurat II, Edurat II AUI ad Edurat IIs stets. Desiged to meet a wide
More informationVCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital
VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital Complex PCI: Multivessel Disease George W. Vetrovec, MD. Kimmerling Chair of Cardiology VCU Pauley Heart Center Virginia
More information